Jefferies Group's TXG Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 14,299 shares of 10x Genomics, Inc. (TXG) worth $233,217, representing 0.00% of the portfolio. First purchased in 2023-Q3, this short-term holding has been held for 8 quarters.
Based on 13F filings, Jefferies Group has maintained this position in TXG for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2024, adding 315,048 shares. Largest reduction occurred in Q4 2024, reducing 284,000 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's 10x Genomics (TXG) Holding Value Over Time
Track share changes against reported price movement
Quarterly 10x Genomics (TXG) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +14,299 | New Buy | 14,299 | $16.31 |
| Q3 2025 | -34,000 | Sold Out | 0 | $0.00 |
| Q2 2025 | -37,425 | Reduce 52.40% | 34,000 | $11.58 |
| Q1 2025 | +40,377 | Add 130.05% | 71,425 | $8.73 |
| Q4 2024 | -284,000 | Reduce 90.14% | 31,048 | $14.36 |
| Q3 2024 | +315,048 | New Buy | 315,048 | $22.58 |
| Q4 2023 | -6,186 | Sold Out | 0 | $0.00 |
| Q3 2023 | +6,186 | New Buy | 6,186 | $41.25 |
Jefferies Group's 10x Genomics Investment FAQs
Jefferies Group first purchased 10x Genomics, Inc. (TXG) in Q3 2023, acquiring 6,186 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held 10x Genomics, Inc. (TXG) for 8 quarters since Q3 2023.
Jefferies Group's largest addition to 10x Genomics, Inc. (TXG) was in Q3 2024, adding 315,048 shares worth $7.11 M.
According to the latest 13F filing for Q4 2025, Jefferies Group's firm, Jefferies Financial Group Inc., owns 14,299 shares of 10x Genomics, Inc. (TXG), valued at approximately $233,217.
As of the Q4 2025 filing, 10x Genomics, Inc. (TXG) represents approximately 0.00% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in 10x Genomics, Inc. (TXG) was 315,048 shares, as reported at the end of Q3 2024.